INS and type 2 diabetes mellitus: All T2D subjects analyzed in this group were on basal insulin (± OHA) and intensified therapy with fast-acting insulin; Table 3 shows clinical and biochemical characteristics of study subjects at the time of intensification of therapy, in each 5-year period.